MedPage Today) — The shortage of semaglutide injections (Ozempic, Wegovy) is over, the FDA announced on Friday.
The agency, along with maker Novo Nordisk, confirmed that supply now meets or exceeds both the current and projected U.S. demand…
Ozempic, Wegovy Shortage Is Officially Over

Leave a Comment Leave a Comment